Recombinant Ehrlichia canis GP19 Protein as a Promising Vaccine Prototype Providing a Protective Immune Response in a Mouse Model

SIMPLE SUMMARY: One of the limitations of vaccine development against E. canis infection is the indefinite knowledge of the protective immunity in the host. In this study, recombinant protein GP19 was produced as a vaccine prototype, rGP19, for inducing protective immune responses in a mouse model a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nambooppha, Boondarika, Rittipornlertrak, Amarin, Muenthaisong, Anucha, Koonyosying, Pongpisid, Chomjit, Paweena, Sangkakam, Kanokwan, Tangtrongsup, Sahatchai, Tiwananthagorn, Saruda, Sthitmatee, Nattawooti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414908/
https://www.ncbi.nlm.nih.gov/pubmed/36006302
http://dx.doi.org/10.3390/vetsci9080386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414908/
https://www.ncbi.nlm.nih.gov/pubmed/36006302
http://dx.doi.org/10.3390/vetsci9080386

Ejemplares similares